S&P/ASX 200 Index (ASX: XJO) shares are down 0.7% to 8,847 points on Monday.
Among the 11 market sectors, the consumer discretionary sector is in the lead today, up 0.5%.
The financials sector is the laggard, down 0.9%, ahead of the Reserve Bank's interest rate announcement tomorrow.
According to the RBA Rate Tracker on the ASX website, traders put a 78% likelihood on a fifth rate hike for 2026.
Let's check out some new ratings on three ASX 200 heavyweight shares for this week.
The PLS share price is $2.61, down 1.1% today and down 17% over 12 months.
Last week, PLS released its September quarter report.
The report revealed record spodumene concentrate production of 267.6kt and revenue of $563 million.
Post quarter, PLS noted the final investment decision taken on the P2000 Project.
P2000 is expected to increase production capacity to about 2.0Mt of spodumene concentrate per year.
The project is under construction, with first ore expected in the September quarter of CY29.
Bell Potter analyst James Williamson has a buy rating on this ASX 200 lithium share.
In a new note, Williamson said:
While P2000 introduces medium-term execution risk, completion will meaningfully strengthen PLS' long-term position as a large, low-cost hard-rock lithium producer.
The company retains offtake optionality with ~50% of FY30 expected SC production of 2Mtpa uncontracted.
The Woolworths share price is $39.62, down 1.5% today and up 40% over 12 months.
Last week, Woolworths released its 1Q FY27 update.
The grocery network reported group sales worth $19.4 billion, up 4.7% on 1Q FY26.
Woolworths' e-commerce sales came in at $3.1 billion, up 16% on 1Q FY26.
Bell Potter analyst Jonathan Snape gives a hold rating to this ASX 200 consumer staples share.
Snape noted a trend in investors turning to defensive sectors in light of market weakness.
This is benefiting Woolworths shares.
Snape said:
A flight to safety is also lifting valuation multiples of Consumer staples of which WOW is a beneficiary.
The ASX 200 has fallen 4.8% from its record high set in August.
The CSL share price is $201.56, up 0.4% today and up 14% over 12 months.
CSL shares have had a comeback in 2026 amid a broader healthcare sector rebound.
The CSL share price fell to a nine-year low of $90 in June before surging 124% to where it is today.
Remo Greco from Sanlam Private Wealth said CSL was recently trading about 10% above its global peers.
This is part of the reason he has a sell rating on the ASX 200 healthcare share.
Greco said (courtesy The Bull):
Despite the company forecasting underlying profit growth of about 5 per cent in fiscal year 2027, we believe the solid outlook is more than factored in to recent price levels.
In our view, the risk-return equation during the next 12 months is unfavourable at this point.
The share price recovery at CSL provides an opportunity to take some profits in favour of companies offering brighter capital growth prospects.
The post Buy, hold, sell: PLS Group, Woolworths, CSL shares appeared first on The Motley Fool Australia.
Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026